- Home
- FOLD vs PAGS Comparison
FOLD vs PAGS Comparison
Compare FOLD & PAGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- PAGS
- Stock Information
- Founded
- FOLD 2002
- PAGS 2006
- Country
- FOLD United States
- PAGS Brazil
- Employees
- FOLD N/A
- PAGS N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- PAGS EDP Services
- Sector
- FOLD Health Care
- PAGS Technology
- Exchange
- FOLD Nasdaq
- PAGS Nasdaq
- Market Cap
- FOLD 2.9B
- PAGS 2.5B
- IPO Year
- FOLD 2007
- PAGS N/A
- Fundamental
- Price
- FOLD $6.83
- PAGS $8.53
- Analyst Decision
- FOLD Strong Buy
- PAGS Buy
- Analyst Count
- FOLD 9
- PAGS 8
- Target Price
- FOLD $17.00
- PAGS $11.63
- AVG Volume (30 Days)
- FOLD 3.9M
- PAGS 4.0M
- Earning Date
- FOLD 05-08-2025
- PAGS 05-22-2025
- Dividend Yield
- FOLD N/A
- PAGS N/A
- EPS Growth
- FOLD N/A
- PAGS 29.76
- EPS
- FOLD N/A
- PAGS 1.07
- Revenue
- FOLD $528,294,999.00
- PAGS $2,964,269,276.00
- Revenue This Year
- FOLD $21.83
- PAGS $18.94
- Revenue Next Year
- FOLD $22.16
- PAGS $6.47
- P/E Ratio
- FOLD N/A
- PAGS $7.96
- Revenue Growth
- FOLD 32.29
- PAGS 16.92
- 52 Week Low
- FOLD $6.20
- PAGS $6.11
- 52 Week High
- FOLD $12.65
- PAGS $14.82
- Technical
- Relative Strength Index (RSI)
- FOLD 32.01
- PAGS 57.44
- Support Level
- FOLD $6.20
- PAGS $8.28
- Resistance Level
- FOLD $6.95
- PAGS $8.61
- Average True Range (ATR)
- FOLD 0.43
- PAGS 0.48
- MACD
- FOLD -0.04
- PAGS 0.04
- Stochastic Oscillator
- FOLD 29.86
- PAGS 93.98
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About PAGS PagSeguro Digital Ltd.
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused primarily on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.